Zura Bio Limited (ZURA) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Zura Bio Limited (ZURA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $312.1M, listed on NASDAQ, employing roughly 30 people, carrying a beta of 0.09 to the broader market. Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. Led by Sandeep C. Kulkarni, public since 2023-03-21.
Snapshot as of May 15, 2026.
- Spot Price
- $4.67
- Total OI
- 6.4K